Australia, Jan. 28 -- Ionis Pharmaceuticals Inc., owns the trademark (2498909) for 'TRYNGOLZA' till April 15, 2034.
Status: protected:
Registered/protected
Classes: 5 [Pharmaceuticals for treatment of genetic diseases and disorders; pharmaceuticals for treatment of cardiovascular, metabolic, neurological, and inflammatory diseases and disorders.], 41 [Education and training services, namely, seminars, providing non-downloadable webinars, and workshops for healthcare professionals, caregivers, patients, and providers in the field of genetic diseases and disorders, online journals, namely, blogs featuring information on genetic diseases and disorders; education and training services, namely, seminars, providing non-downloadable webinars, an...